Cereno Scientific reported a successful meeting with the FDA on the design of a future clinical trial for its PAH therapy ...

Immunic’s lead oral small molecule has failed to hit the primary endpoint of a phase 2 trial in patients with progressive ...

Therini Bio reveals promising Phase 1a trial results for THN391, a potential breakthrough treatment for neurodegenerative ...

“This is a clear and deliberate shift,” Corbett says.

The FDA made a historic decision to phase out animal testing and switch to human-relevant methods in drug testing and ...

Donald Trump and RFK have caused mayhem in the US medical research market. It's clearing a path for Aussie drug trial contractor IDT.

The drug cytisinicline could help expand options for quitting smoking, and if approved by the FDA, would be the first new ...

This article is authored by Aditya Sharma, head, Process Solutions, India Region, Merck Life Science, New Delhi.

Learn how UC Davis’ Aggie Square is solving pressing challenges through collaborative research and cutting-edge technology.

Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...

Discover six hemophilia companies developing new treatments for the genetic bleeding disorder, from gene therapies to RNAi ...